Therasense Stock Analysis
| THER Stock | USD 0.0001 0.00 0.00% |
Therasense is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Therasense pink sheet analysis is to determine its intrinsic value, which is an estimate of what Therasense is worth, separate from its market price. There are two main types of Therasense's stock analysis: fundamental analysis and technical analysis.
The Therasense pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Therasense |
Therasense Pink Sheet Analysis Notes
About 84.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Therasense recorded a loss per share of 0.0. The entity had not issued any dividends in recent years. The firm had a split on the 12th of September 2019. Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.The quote for Therasense is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Therasense contact the company at 720 420 0074 or learn more at https://theralink.com.Therasense Investment Alerts
| Therasense generated a negative expected return over the last 90 days | |
| Therasense has some characteristics of a very speculative penny stock | |
| Therasense has a very high chance of going through financial distress in the upcoming years | |
| Therasense currently holds 2.9 M in liabilities. Therasense has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Therasense until it has trouble settling it off, either with new capital or with free cash flow. So, Therasense's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Therasense sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Therasense to invest in growth at high rates of return. When we think about Therasense's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 353.26 K. Net Loss for the year was (7.75 M) with profit before overhead, payroll, taxes, and interest of 256.68 K. | |
| Therasense currently holds about 127.82 K in cash with (5.54 M) of positive cash flow from operations. | |
| Roughly 84.0% of the company outstanding shares are owned by corporate insiders |
Therasense Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Therasense's market, we take the total number of its shares issued and multiply it by Therasense's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Therasense, as well as the relationship between them.Therasense Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Therasense middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Therasense. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Therasense Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Therasense prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Therasense shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Therasense. By using and applying Therasense Pink Sheet analysis, traders can create a robust methodology for identifying Therasense entry and exit points for their positions.
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Therasense to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.